NCT07423078 2026-04-13
WOLF
University of Pittsburgh
Phase 2 Recruiting
Clinical Trials
6 trialsNCT05635643 2026-03-19
Study of CHS-114 in Participants With Advanced Solid Tumors
Coherus Oncology, Inc.
Phase 1 Recruiting
NCT07088211 2025-07-31
Sacituzumab Tirumotecan and Toripalimab in the First-line Treatment of HNSCC
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 2 Recruiting
NCT06378177 2024-06-27
A Study of LVGN6051 Combination Therapy in Patient With Head and Neck Squamous Cell Carcinoma (HNSCC)
Lyvgen Biopharma Holdings Limited
Phase 2 Recruiting
NCT05125055 2023-11-22
Neoadjuvant Anti-PD-1 and TP Versus TPF on Pathological Response in OSCC
Shanghai Jiao Tong University School of Medicine
Phase 2/3 Recruiting
NCT04807140 2023-04-14
Neoadjuvant Toripalimab or Toripalimab in Combination With Carboplatin and Nab-paclitaxel in Untreated HNSCC (HNSCC-002)
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2 Recruiting